Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-09-30
2008-09-30
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S469000, C548S490000, C548S491000, C514S415000
Reexamination Certificate
active
10521175
ABSTRACT:
The present invention provides an indoline compound represented by the formula (I)wherein each symbol is as defined in the DESCRIPTION, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing this indoline compound or a pharmaceutically acceptable salt thereof. The compound of the present invention shows superior ACAT inhibitory effect and superior lipoperoxidation inhibitory effect and is useful as an ACAT inhibitor or a lipoperoxidation inhibitor.
REFERENCES:
patent: 4013404 (1977-03-01), Parent et al.
patent: 4435406 (1984-03-01), Krasso et al.
patent: 4599347 (1986-07-01), Krasso et al.
patent: 4803218 (1989-02-01), Stanley et al.
patent: 4956372 (1990-09-01), Kojima et al.
patent: 5091419 (1992-02-01), Ito et al.
patent: 5143919 (1992-09-01), Meguro et al.
patent: 5153226 (1992-10-01), Chucholowski et al.
patent: 5166429 (1992-11-01), Ito et al.
patent: 5219859 (1993-06-01), Festal et al.
patent: 5227492 (1993-07-01), Ito et al.
patent: 5254565 (1993-10-01), Meguro et al.
patent: 5254590 (1993-10-01), Malen et al.
patent: 5256782 (1993-10-01), Meguro et al.
patent: 5258405 (1993-11-01), Ito et al.
patent: 5384425 (1995-01-01), Ito et al.
patent: 5420348 (1995-05-01), Ito et al.
patent: 5767129 (1998-06-01), Yuen
patent: 5990150 (1999-11-01), Matsui et al.
patent: 5994040 (1999-11-01), Morishima et al.
patent: 6063806 (2000-05-01), Kamiya et al.
patent: 6127403 (2000-10-01), Matsui et al.
patent: 6169107 (2001-01-01), Kitano et al.
patent: 6200988 (2001-03-01), Kamiya et al.
patent: 6248772 (2001-06-01), Kitano et al.
patent: 6414012 (2002-07-01), Matsui et al.
patent: 6489475 (2002-12-01), Matsui et al.
patent: 0 512 570 (1992-11-01), None
patent: 0 622 356 (1994-11-01), None
patent: 0 708 091 (1996-04-01), None
patent: 0 782 986 (1997-07-01), None
patent: 0 793 140 (1997-09-01), None
patent: 2-117651 (1990-05-01), None
patent: 3-7259 (1991-01-01), None
patent: 3-148247 (1991-06-01), None
patent: 4-66568 (1992-03-01), None
patent: 4-234839 (1992-08-01), None
patent: 4-327564 (1992-11-01), None
patent: 5-32666 (1993-02-01), None
patent: 5-97802 (1993-04-01), None
patent: 5-140102 (1993-06-01), None
patent: 8-92210 (1996-04-01), None
patent: 8-208602 (1996-08-01), None
patent: 2002-47269 (2002-02-01), None
patent: 2002-302481 (2002-10-01), None
patent: 96/09287 (1996-03-01), None
patent: 97/12860 (1997-04-01), None
patent: 2004/096767 (2004-11-01), None
US 6,204,392, 03/2001, Matsui et al. (withdrawn)
V. DeVries et al., “Potential Antiatherosclerotic Agents .5.1An Acyl-CoA:Cholesterol O-Acyltransferase Inhibitor with Hypocholesterolemic Activity”, J. Med. Chem., vol. 29, 1986, pp. 1131-1133.
Fredrick J. Brown et al., “Evolution of a Series of Peptidoleukotriene Antagonists: Synthesis and Structure-Activity Relationships of 1,6-Disubstituted Indoles and Indazoles”, J. Med. Chem., vol. 33 (6), 1990 pp. 1771-1781.
Victor G. Matassa et al., “Evolution of a Series of Peptidoleukotriene Antagonists: Synthesis and Structure/Activity Relationships of 1,3,5-Substituted Indoles and Indazoles”, J. Med. Chem., vol. 33(6), 1990, pp. 1781-1790.
K. Yee et al., “Novel Series of Selective Leukotriene Antagonists: Exploration and Timization of the Acidic Region in 1,6-Disubstituted Indoles and Indazoles1”, J. Med. Chem., vol. 33(9) 1990, pp. 2437-2451.
Ikai Miho
Kamiya Shouji
Kasai Masayasu
Shirahase Hiroaki
Takahash Kenji
Kyoto Pharmaceutical Industries, Ltd.
Shameem Golam M
Wenderoth Lind & Ponack LLP
LandOfFree
Indoline compound and medicinal use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indoline compound and medicinal use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoline compound and medicinal use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3939163